Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$AGBA and TRILLER SOON TO BE TRADED ON NASDAQ UNDER TICKER "ILLR"
SHAREHOLDERS MEETING TO BE HELD ON SEPTEMBER 19, 2024
$PJET https://www.telluridehealthcompany.com/ while these trips are still good
$TREP Q earning 90% higher year over year expect to test .30 cents today
$PURA, $PJET, $USMJ, $NOUV, & $KALY might all merge one day into a super power do some DD barchart ratings are great.
$AEGY - http://pharmajanes.com website up!!!
$MINE! Looks beautiful today!
Sounds Great Logicalcash, thank you very much and I did member mark you, thanks for the info. Lets Rollllllllllll
Friday, April 12, 2013
TRULAN RESOURCES INC. Financials
EDGAR Online Financials (Fri, Apr 12)
$VSTA Headlines
http://finance.yahoo.com/q/h?s=VSTA+Headlines
Wednesday, March 13, 2013
VISTAGEN THERAPEUTICS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an O
EDGAR Online (Wed, Mar 13)
http://biz.yahoo.com/e/130313/vsta8-k.html
Tuesday, March 12, 2013
VistaGen Therapeutics to Present Enhancements and Expanded Validation of LiverSafe 3D(TM) at Society of Toxicology's 52nd Annual Meeting
Marketwire (Tue, Mar 12)
http://finance.yahoo.com/news/vistagen-therapeutics-present-enhancements-expanded-150517204.html
Monday, March 11, 2013
VistaGen Therapeutics to Present CardioSafe 3D(TM) Developments at Society of Toxicology's 52nd Annual Meeting
Marketwire (Mon, Mar 11)
http://finance.yahoo.com/news/vistagen-therapeutics-present-cardiosafe-3d-140000662.html
Wednesday, March 6, 2013
VISTAGEN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial S
EDGAR Online (Wed, Mar 6)
http://biz.yahoo.com/e/130306/vsta8-k.html
Monday, March 4, 2013
VistaGen Therapeutics Enters Strategic Collaboration With Celsis to Further Advance LiverSafe 3D(TM)
Marketwire (Mon, Mar 4)
http://finance.yahoo.com/news/vistagen-therapeutics-enters-strategic-collaboration-140000133.html
Thursday, February 28, 2013
VISTAGEN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fina
EDGAR Online (Thu, Feb 28)
http://biz.yahoo.com/e/130228/vsta8-k.html
Thursday, February 21, 2013
VISTAGEN THERAPEUTICS, INC. Financials
EDGAR Online Financials (Thu, Feb 21)
http://finance.yahoo.com/q/is?s=vsta
Thursday, February 14, 2013
VISTAGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Feb 14)
http://biz.yahoo.com/e/130214/vsta10-q.html
Thursday, February 7, 2013
VistaGen's Collaborators Identify Definitive Precursor for Adult Blood and the Immune System
Marketwire (Thu, Feb 7)
http://finance.yahoo.com/news/vistagens-collaborators-identify-definitive-precursor-150633334.html
Wednesday, January 23, 2013
Vistagen Therapeutics Successfully Completes Final Phase 1 Safety Study of AV-101Marketwire (Wed, Jan 23)
http://finance.yahoo.com/news/vistagen-therapeutics-successfully-completes-final-133000505.html
PWei read the news today -->
Feb 12th, 2013
PacWest Equities, Inc. Announces the Signing of Agreement to Acquire the Solar Technology Line of CIGS Technology From DayStar Technologies, Inc. (NASDAQ-DTSI) in a Deal Some Analysts Value in Excess of $50 Million
LAS VEGAS, NV--(Marketwire - Feb 12, 2013) - PacWest Equities, Inc. ( PINKSHEETS : PWEI ) announced today the completion of an agreement to acquire the Solar Technology Line of CIGS technology from DayStar Technologies, Inc. ( NASDAQ : DSTI ), in a deal some analysts value in excess of $50 Million. The transaction includes the ownership of all of DayStar's solar assets, including their proprietary, differentiated manufacturing process to produce low-cost, monolithically integrated, silicon-free, CIGS-on-glass modules that address the grid-tied, ground-based Solar (PV) market...
5/28/12 (Week of) Promotional Watch List
GWBU - 126 newsletters total. Rumored 10 million promotional budget.
** Watch for $1.65+ it will go parabolic at 1.75 it will breakout.
VPER - Promoter: 1-2-3 Stock Alerts
Compensation: Global Marketing Media, LLC has been compensated thirty thousand dollars for a one day marketing and promotional effort on VPER by Kolo Media Group, LLC.
ORYN - Keep this on your watch list. Round 2 includes hard mailers.
StockProfessors.com is a wholly owned subsidiary of Raven Consulting Corp. Raven Consulting Corp expects to be compensated up to $25,000.00 for this ORYN advertising and promotion by Colburg Media Inc., a third party.
SUNB - Is being promoted by StockMister. With a $110,000 budget
Could SUNB be TBX and/or BDPS call next week???
. StockMister.com has been compensated a total One-Hundred and Ten Thousand Dollars for the current 1 week and past 1 week marketing efforts regarding SUNB by a third party (Equities Awareness Group, LLC).
LYJN -Def Leppard launch Rock of Ages T-shirt line.
Read more: http://www.3news.co.nz/Def-Leppard-launch-Rock-of-Ages-T-shirt-line/tabid/418/articleID/254765/Default.aspx#ixzz1vC4GgUSv
http://www.imdb.com/title/tt1336608/
Lyric Culture(LYJN) continues to put out collection after collection of tees, jewelry, etc. with major retailers. Keep an eye on this one! Plenty of good DD on our board.
Our picks have gone through the roof this year! Over 800% in gains since January! Official announcements on Twitter only!
Follow us
twitter.com/DITRStocks
SNET had nice volume yesterday and strong green candle
SNET Profile Data
SIC - Industry Classification 7514 - Passenger car rental
Business Status Development Stage Company a/o Oct 10, 2011
Incorporated In: DE, USA
Year of Inc. 1993
Employees 16 a/o Oct 10, 2011
looking into PPBL based on nice day today
PPBL Security Details
Share Structure
Market Value1 $900,106 a/o Apr 23, 2012
Shares Outstanding 120,014,199 a/o Mar 31, 2012
Float 35,000,000 a/o Aug 09, 2010
Authorized Shares 100,000,000 a/o Aug 02, 2010
Par Value No Par Value
Business Description
The company will be making a transition from a publishing company to a company exploring opportunities in fragmented industries where there is the potential to initiate a "roll-up" strategy which will be driven by leveraged transactions
Notice:
CapYield is almost done. Bear the wait everyone, it'll be worth it.
$STVF is up nearly 150% since the 21st!
LAST above average volume again today up 4% currently with only 400k in float, won't take much to move into 3.00 imo
LAST mentioned this morning on STT radio show getting some love
LLos Angeles Syndicate of Technology Announces Successful Launches of First Three Portfolio Companies
SANTA MONICA, Calif., March 27, 2012 /PRNewswire via COMTEX/ -- Los Angeles Syndicate of Technology, Inc. (OTCQB: LAST), a Business Development Company (BDC) that incubates early stage technology companies, has announced the successful launches of the first three portfolio companies built within its technology incubator. LAST is the largest shareholder of each of the three companies including Sanguine Biosciences, a bio-specimen supplier; Virurl, Inc., a social advertising platform; and Stocktown Productions, a digital production studio.
"We are encouraged that our first three portfolio companies are generating revenue and expanding operations," said Bryce Knight, CEO of LAST. He added "We are excited to bring new team members into the LAST network to support the growth of these companies and to continue developing our second class of companies under the LAST umbrella."
About Los Angeles Syndicate of Technology - www.last.vc
Los Angeles Syndicate of Technology, Inc. (OTC: LAST) is a publicly traded Business Development Company (BDC) that creates, builds, and invests in web and mobile technology companies. LAST develops digital media, consumer internet, and social networking products in its technology incubator, and has a portfolio of six companies at different stages of development. LAST's mission is to foster technology innovation in Los Angeles by partnering with the most talented entrepreneurs of southern California and providing them with the capital, support and tools to bring their ideas to market and commercialize their products.
About Sanguine Biosciences, Inc. - sanguinebio.com
Sanguine Biosciences, Inc. ("Sanguine") is an international supplier of DNA data and bio-specimen to research organizations for the development of personalized medicines. Sanguine provides highly viable primary human cells and tissues to both the academic and industrial life science research communities through a new direct-to-patient platform. The current product offering spans customers' needs in the In Vitro Research & Development stage of Drug Development. Sanguine's vision is to develop into the global leader in high quality cells and tissues for life science research and development.
About Virurl, Inc. - virurl.com
Virurl, Inc. ("Virurl") is an online advertising platform that allows advertisers to incentivize people to share links with their friends. By creating a forum where users are rewarded for sharing links, the VIRURL platform empowers content creators and advertisers to tap the organic social networks of the web to drive traffic to their sites. Virurl is a "human-powered" advertising engine, enabling users to earn cash and rewards for what they are already doing everyday - sharing links with their friends.
About Stocktown Productions, Inc. - stocktownproductions.com
Stocktown Productions, Inc. ("Stocktown") is a digital production studio based in Santa Monica, California, specializing in video, animation and 3-D visual effects. In addition to video production, Stocktown provides innovative web and graphic design - bringing an original style and cutting-edge concepts to each project.
Forward-Looking Statements
Statements included in this release related to Los Angeles Syndicate of Technology, Inc. and its portfolio companies constitute or may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as the inherent uncertainty of investing in early-stage technology companies, the technological and financial difficulties inherent in these activities, and the Company's ability to estimate accurately net revenues due to variability in size, scope and duration of projects. Further information on potential risk factors that could affect the Company's financial results can be found in the Company's reports filed with the Securities and Exchange Commission.
SOURCE Los Angeles Syndicate of Technology, Inc.
www.prnewswire.com
Copyright (C) 2012 PR Newswire. All rights reserved
-0- AST NEWS
11 Million OS could move nicely
sbfm mentioned here:) studies must be doing really well, they are presenting at huge cancer conference next week! 9 million float
Sunshine Biopharma and Binghamton University to Present New Data at the Upcoming American Association for Cancer Research Meeting in Chicago
MONTREAL, Mar 26, 2012 (BUSINESS WIRE) -- Sunshine Biopharma, Inc. (OTCBB: SBFM), which has designed and synthesized a new compound, Adva-27a, that acts as an inhibitor of multidrug resistant breast cancer cells in vitro, today announced that it will be presenting new scientific data at the American Association for Cancer Research Meeting March 31-April 4, 2012, in Chicago, Illinois, together with its research collaborator, Binghamton University, a State University of New York.
According to the American Cancer Society, approximately 1.5 million new cases of cancer are diagnosed each year in the U.S. Of these, over 230,000 are new breast cancer cases. The American Cancer Society also reports that there are over 11 million Americans living with cancer. Of these, 2.5 million are breast cancer patients. Virtually all cancers types are either aggressive at the onset or become aggressive or multidrug resistant over time. Currently, there are little or no treatment options available for multidrug resistant breast cancer patients.
The data concerning Adva-27a, which will be presented at the Chicago meeting by the Company’s research collaborator, Dr. Susannah Gal of Binghamton University, show that Adva-27a efficiently kills multidrug resistant breast cancer cells in vitro. “If the activity of Adva-27a proves to be as remarkable in vivo, this new compound would represent a breakthrough for breast cancer patients,” said Dr. Steve N. Slilaty, CEO of Sunshine Biopharma.
VPER MOMO alert today again. Good morning all
evph very nice
rcfef evtn and good ones to have on radar as well imo
GTRL, SNPK, SLMU, and EVPH are some some stocks to watch today folks.
CleanTech: www.evtn.com : EVTN is a cleantech manufacturer with the potential solution to effective oil spill response. EVTN sells the world’s most efficient fluid and fluid/solid separator. Patented technology, no competitive equipment can approach its capabilities for tasks like oil/water/sand separation in the energy industry. Separation is a core process in many global industries from food processing to clean water treatment. EVTN has systems in use or orders pending with some of the world’s largest companies. The company welcomes customer and investor contacts.
want a diamond in the rough? this one is going to be sparkling so much, it will be blinding imo
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |